2-31524840-T-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000348.4(SRD5A2):​c.*1356A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00864 in 226,866 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0082 ( 9 hom. )

Consequence

SRD5A2
NM_000348.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.254
Variant links:
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-31524840-T-G is Benign according to our data. Variant chr2-31524840-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 97418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00884 (1346/152276) while in subpopulation NFE AF= 0.0113 (768/68018). AF 95% confidence interval is 0.0106. There are 15 homozygotes in gnomad4. There are 650 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SRD5A2NM_000348.4 linkuse as main transcriptc.*1356A>C 3_prime_UTR_variant 5/5 ENST00000622030.2
SRD5A2XM_011533069.3 linkuse as main transcriptc.*1356A>C 3_prime_UTR_variant 5/5
SRD5A2XM_011533072.3 linkuse as main transcriptc.*1356A>C 3_prime_UTR_variant 7/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SRD5A2ENST00000622030.2 linkuse as main transcriptc.*1356A>C 3_prime_UTR_variant 5/51 NM_000348.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00883
AC:
1343
AN:
152158
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00601
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00557
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0186
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0113
Gnomad OTH
AF:
0.0110
GnomAD4 exome
AF:
0.00825
AC:
615
AN:
74590
Hom.:
9
Cov.:
0
AF XY:
0.00830
AC XY:
285
AN XY:
34340
show subpopulations
Gnomad4 AFR exome
AF:
0.00487
Gnomad4 AMR exome
AF:
0.00433
Gnomad4 ASJ exome
AF:
0.00233
Gnomad4 EAS exome
AF:
0.0000939
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0417
Gnomad4 NFE exome
AF:
0.0112
Gnomad4 OTH exome
AF:
0.00970
GnomAD4 genome
AF:
0.00884
AC:
1346
AN:
152276
Hom.:
15
Cov.:
32
AF XY:
0.00873
AC XY:
650
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00604
Gnomad4 AMR
AF:
0.00562
Gnomad4 ASJ
AF:
0.00231
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.0186
Gnomad4 NFE
AF:
0.0113
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.00951
Hom.:
11
Bravo
AF:
0.00784
Asia WGS
AF:
0.00173
AC:
7
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
not provided, no classification providedliterature onlyUniversity of Sydney Medical Foundation-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.91
DANN
Benign
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28383087; hg19: chr2-31749910; API